
IDEAS TO IND — YOUR PATHWAY TO DISCOVERY
ONE PARTNER
EVERY STAGE
20
Years of Genetic Innovation
7,000
Global Bioscience Partners
50,000
Mouse & Rat Models Delivered
10,925
SCI Journal Citations
250,000
SPF Animals in AAALAC-Accredited Facilities
Animal
Innovative Solutions & Trusted Products
Special Promotions & Discounts
See All Promotions
special offer
Flash Drop — Ready-to-Ship KO/CKO Mice
Unlock fast, budget-friendly access to KO/CKO mouse lines from Cyagen’s MouseAtlas.we will release exclusive flash deals on selected knockout and conditional knockout strains in real-time– helping you launch or expand your in vivo studies without long lead times or high upfront costs.
Explore

Free Trial
OK to Switch - Introducing the Locally Bred NKG Mice
Cyagen is inviting researchers to experience the benefits of our NKG mice breed in the US. This "OK to Switch" offer is designed to help you easily transition from your current models with zero risk and gap.
Explore

Special Offer
Cell Line Project Special Offer
Get guaranteed, publication-ready cell lines without the endless troubleshooting. For a limited time, let our experts deliver your custom model for 50% less
Explore

Your Partners in Preclinical Progress
Pioneering life science advancements to deliver real-world health solutions.
Our Solutions: Integrated preclinical services, including:
- ● Cell & animal model development and viral packaging.
- ● Expert-led preclinical studies.
Your Outcome: Seamlessly translating innovative research into actionable results and successful IND applications.
Citation Database
Molecular Therapy: Methods & Clinical Development, March, 2025
Intracranial AAV administration dose-dependently recruits B cells to inhibit the AAV redosing
【Other】
Gut, February, 2025
E-twenty-six-specific sequence variant 5 (ETV5) facilitates hepatocellular carcinoma progression and metastasis through enhancing polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC)-mediated immunosuppression
【Other】
Cell Death & Disease, February, 2025
Mcm5 mutation leads to silencing of Stat1-bcl2 which accelerating apoptosis of immature T lymphocytes with DNA damage
【Other】
Molecular Therapy, February, 2025
Single-cell data-driven design of armed oncolytic virus to boost cooperative innate-adaptive immunity against cancer
【Other】
Resource Library
BLOG & INSIGHTS
More Insights

Breakthrough Glaucoma Research: Leveraging ANGPTL7 Humanized Models for Gene Therapy
As World Glaucoma Week highlights the global burden of blindness, discover how targeting ANGPTL7 with humanized mouse models and integrated CRO services is revolutionizing the development of next-generation ophthalmic gene therapies.
March 26, 2026
Schedule Meeting
UPCOMING EVENT
More

Life Science Exhibits at Vanderbilt University
Cyagen will be attending the Life Science Exhibits at Vanderbilt University on Apr 7. Our experts will be available to discuss advanced techniques in genetically engineered mouse model generation and explore how next-generation customized animal models can support and accelerate academic research.
Schedule Meeting








